Extramammary Paget's disease of the oral mucosa with in situ carcinoma of minor salivary gland ducts.

Department of Pathology, Southampton General Hospital, England.
American Journal of Surgical Pathology (Impact Factor: 4.59). 12/1988; 12(11):890-5. DOI: 10.1097/00000478-198811000-00010
Source: PubMed

ABSTRACT This paper describes a case of oral extramammary Paget's disease associated with widespread in situ carcinoma of minor salivary gland ducts and invasive, poorly differentiated carcinoma. Clinically, the case was characterized by unusually extensive and rapidly spreading erythroplakia of the oral mucosa, accompanied by a relatively small invasive salivary gland carcinoma. Despite the similarities of breast and salivary tissue, oral extramammary Paget's disease appears to be extremely rare.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Salivary duct carcinoma is a high-grade malignant tumor arising predominantly in the major salivary glands. We describe herein a rare presentation of salivary duct carcinoma arising in the submandibular gland and showing pagetoid spread to the oral mucosa. A 46-year-old man was admitted with a 2-year history of swelling in the floor of the mouth. Resection of the submandibular gland tumor was followed by mucosal biopsy around the aperture of the right Wharton's duct. The tumor recurred in the oral mucosa with pagetoid spread and extended widely in the oral cavity for the following 10 years, despite chemo- and radiotherapy. Mucosal spread, although a relatively remote possibility, can occur in the setting of salivary duct carcinoma.
    Human pathology 04/2009; 40(7):1036-9. DOI:10.1016/j.humpath.2008.11.016 · 2.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To describe three cases of purely in situ salivary duct carcinoma, so as better to define the entity. Three primary tumours of the parotid gland are presented, in each case composed of cysts and ducts and lined by high nuclear grade epithelial cells. All parts of each tumour were surrounded by a myoepithelial cell rim and there was no evidence of invasion. The tumour cells expressed immunohistochemical markers seen in invasive salivary duct carcinoma of usual (high-grade) type. In two cases the androgen receptor (AR) reaction was strong, but there was no immunohistochemical expression of HER2 protein or gene amplification by in situ hybridization. In the remaining case, fewer nuclei stained for AR, but both HER2 protein and gene amplification were demonstrated. Salivary duct carcinoma in situ is morphologically similar to breast ductal carcinoma in situ and, although our cases are few, salivary duct carcinoma in situ can possibly be subdivided into luminal and non-luminal cell types, as can analogous mammary neoplasms. The present study cannot determine whether low-grade cribriform cystadenocarcinoma, architecturally similar but immunohistochemically different, is part of the spectrum of salivary duct carcinoma in situ, or whether it represents a separate entity.
    Histopathology 11/2008; 53(4):416-25. DOI:10.1111/j.1365-2559.2008.03135.x · 3.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background The survival rates and prognostic factors for salivary duct carcinoma (SDC) are not clear.Methods Survival estimates and prognostic factors were evaluated for 228 patients with SDC identified from the Surveillance, Epidemiology, and End Results (SEER) database.ResultsMedian overall survival (OS) duration for patients with SDC was 79 months and 5-year disease-specific survival (DSS) rate was 64%. Among patients with SDC with lymph node involvement, larger primary tumor size (>3 cm) was associated with twice the risk of death (p < .03). Factors predictive of improved DSS were age (p = .01), tumor size (p = .006), tumor grade (p = .02), and lymph node involvement (p < .001). Adjuvant radiotherapy did not improve survival when compared to surgery alone for early-stage (I–II) disease (p = .28).Conclusion Younger patients with SDC (<50 years) showed a better prognosis. Primary tumor size and lymph node involvement were independent and additive risk factors for poor prognosis. The role of adjuvant radiotherapy in the treatment of SDC needs to be explored further. © 2013 Wiley Periodicals, Inc. Head Neck 36: 694–701, 2014
    Head & Neck 05/2014; 36(5). DOI:10.1002/hed.23350 · 2.83 Impact Factor